NCT07058402

Brief Summary

This is a multicenter, randomized controlled trial comparing retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath with standard percutaneous nephrolithotomy (PCNL) for the treatment of 2-3 cm unilateral renal stones. The aim is to evaluate the clinical efficacy and safety of the novel suction sheath-assisted RIRS compared to standard PCNL in terms of stone-free rate and postoperative complications. A total of 308 patients will be enrolled across four centers in China.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
308

participants targeted

Target at P75+ for not_applicable

Timeline
2mo left

Started Apr 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress88%
Apr 2025Jun 2026

Study Start

First participant enrolled

April 1, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

May 28, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2026

Expected
Last Updated

July 10, 2025

Status Verified

April 1, 2025

Enrollment Period

1.1 years

First QC Date

May 28, 2025

Last Update Submit

July 7, 2025

Conditions

Keywords

Renal CalculiPercutaneous NephrolithotomyPCNLRetrograde Intrarenal SurgeryRIRSFlexible Suction Access Sheath

Outcome Measures

Primary Outcomes (1)

  • Stone-Free Rate (SFR)

    The proportion of participants who are stone-free after the procedure, defined as no residual stones or residual fragments \<2 mm based on postoperative plain abdominal X-ray or non-contrast CT scan.

    3 months postoperatively

Secondary Outcomes (1)

  • Incidence of Postoperative Infection (SIRS Criteria)

    Within 72 hours postoperatively

Study Arms (2)

Retrograde Intrarenal Surgery (RIRS) with Tip-Flexible Suction Access Sheath

EXPERIMENTAL

Participants in this group will undergo retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath for the treatment of 2-3 cm unilateral renal stones.

Procedure: Retrograde Intrarenal Surgery (RIRS) with Tip-Flexible Suction Access Sheath

Standard Percutaneous Nephrolithotomy (PCNL)

EXPERIMENTAL

Participants in this group will undergo standard percutaneous nephrolithotomy (PCNL) for the treatment of 2-3 cm unilateral renal stones.

Procedure: Standard Percutaneous Nephrolithotomy (PCNL)

Interventions

Participants undergo retrograde intrarenal surgery (RIRS) using a tip-flexible suction access sheath. The procedure involves the insertion of a flexible ureteroscope through the urethra and ureter into the kidney. A novel access sheath with tip-flexible and suction capabilities is used to facilitate stone fragmentation and removal. The goal is to improve stone clearance and reduce intrarenal pressure during the procedure.

Retrograde Intrarenal Surgery (RIRS) with Tip-Flexible Suction Access Sheath

Participants undergo standard percutaneous nephrolithotomy (PCNL). The procedure involves creating a percutaneous tract into the renal collecting system under imaging guidance, followed by nephroscope insertion to fragment and extract 2-3 cm renal stones. This represents the current standard of care for large renal calculi.

Also known as: RIRS with Tip-Flexible Suction Access Sheath
Standard Percutaneous Nephrolithotomy (PCNL)

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age between 18 and 80 years
  • American Society of Anesthesiologists (ASA) physical status classification of I-III
  • Single renal stone with a diameter between 2-3 cm confirmed by non-contrast CT scan
  • Signed written informed consent and willingness to comply with study procedures

You may not qualify if:

  • Anatomical abnormalities of the urinary tract (e.g., horseshoe kidney, ileal conduit)
  • Uncontrolled urinary tract infection
  • Absolute contraindications for RIRS or PCNL
  • Inability to understand or complete study documentation
  • Failure to follow study protocol or attend follow-up
  • Patients requiring urgent rescue or at high risk for irreversible harm during surgery
  • Patients who voluntarily withdraw from the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Changhai Hospital, Naval Medical University

Shanghai, Shanghai Municipality, 200433, China

RECRUITING

Related Publications (2)

  • Skolarikos A, Jung H, Neisius A, et al. EAU Guidelines on Urolithiasis 2024. European Association of Urology. https://uroweb.org/guidelines/urolithiasis

    BACKGROUND
  • Zeng G, Traxer O, Zhong W, Osther P, Pearle MS, Preminger GM, Mazzon G, Seitz C, Geavlete P, Fiori C, Ghani KR, Chew BH, Git KA, Vicentini FC, Papatsoris A, Brehmer M, Martinez JL, Cheng J, Cheng F, Gao X, Gadzhiev N, Pietropaolo A, Proietti S, Ye Z, Sarica K. International Alliance of Urolithiasis guideline on retrograde intrarenal surgery. BJU Int. 2023 Feb;131(2):153-164. doi: 10.1111/bju.15836. Epub 2022 Jul 12.

    PMID: 35733358BACKGROUND

MeSH Terms

Conditions

NephrolithiasisKidney Calculi

Condition Hierarchy (Ancestors)

Kidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesUrolithiasisMale Urogenital DiseasesUrinary CalculiCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 28, 2025

First Posted

July 10, 2025

Study Start

April 1, 2025

Primary Completion

April 30, 2026

Study Completion (Estimated)

June 30, 2026

Last Updated

July 10, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will not share

Locations